Rheumatology latest news

We have been advised by Sandoz that there are significant supply issues currently with Hyrimoz and Erelzi medications. This may require some patients to have a brand change of their current treatment. If you are going to be affected by this you will be contacted individually.

Patients on subcutaneous Methotrexate (Metoject) will notice a change to the device in the next few weeks. We will be getting letters out to patients to advise them of this however some patients have made us aware their device has already changed. We anticipate that the device will be more user-friendly for our patients.

We have been advised by Bristol-Myers Squibb that there is a shortage of Abatacept (Orencia) pens. This is likely to last for some time and may require patients to receive intravenous infusions of their medication in their homes in the meantime.